First FDA-cleared autonomous AI makes new moves in healthcare diagnostics

The first autonomous AI system authorized by the FDA, for diagnosing diabetic retinopathy, has raised $75M in a series B funding round.
The first autonomous AI system authorized by the FDA, for diagnosing diabetic retinopathy, has raised $75M in a series B funding round.Read More